Alteogen Inc., a South Korea-based biopharmaceutical company specialising in platform technologies, has entered into an ...
On 29 September, the second compliance date under Proclamation 11020 arrives. From that moment, every pharmaceutical imp...
AsymBio, a China-based biologics-focused Contract Development and Manufacturing Organization (CDMO) and a subsidiary of ...
South Korea-based Ainex Corporation, a medical AI company specialising in gastrointestinal endoscopy, has signed an agre...
Fujifilm Corporation and Taiho Pharmaceutical have entered into a strategic partnership agreement for the development of...
CREATE Medicines, Inc., a US-based clinical-stage biotechnology company pioneering in vivo immune programming, has annou...
RESILIA tissue has been positioned as a significant advancement in valve technology. How does RESILIA tissue differ from...
Bispecific antibodies have transformed treatment by simultaneously targeting two molecules, delivering significant clini...
Although each rare disease affects only a small number of people, collectively they represent one of the world's largest...
Hong Kong headquartered Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discover...
Amorepacific Holdings has signed a strategic investment agreement with Korean startup HIGHER Corporation, a medical aest...
Ember LifeSciences, Inc. has entered into a capital and business alliance with Alfresa Corporation, a subsidiary of Alfr...
Japan-based Ono Pharmaceutical and US-based Phylo, Inc. have announced a collaboration that brings Biomni Lab, Phylo's a...
DKSH Business Unit Healthcare, a strategic healthcare solutions partner and leading provider of Market Expansion Service...
Melbourne- and Boston-based medical device company Navi Medical Technologies has closed a $A6.8 million capital raise to...
BioSpectrum Asia launched the APAC Bioeconomy Index 2026, the first independent, region-native benchmark of Asia-Pacific...
Asia's biopharmaceutical manufacturing sector is entering a new phase of growth, driven by expanding biologics pipelines...
AsymBio, a biologics-focused Contract Development and Manufacturing Organization (CDMO) and a subsidiary of Asymche...
The globally active life science company Eppendorf SE is taking the next major step in expanding its international manuf...
Nippon Kayaku and Celltrion Healthcare Japan K.K. have entered into a Memorandum of Understanding (MoU) on Compreh...
Harbour BioMed, a US-based biopharmaceutical company, has entered into a strategic collaboration with China Nationa...
US-based Waters Corporation has announced the launch of the Xevo TQ Absolute XR IVD Mass Spectrometer, expanding it...
HoneyNaps has officially registered as a Contract Research Organization (CRO) with the Korea National Enterprise for Cli...
Hong Kong-based Home Control International has announced that its wholly-owned subsidiary, Orbiva has entered into ...
Japan-based Shimadzu Corporation has announced the release of the GCMS-TQ8040 RX and GCMS-TQ8050 RX gas chromatogra...